Stablecoin Development 

€0
0
+€0+0% 今天

統計

當日最高
-
當日最低
-
52週高點
-
52週低點
-
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

財報

7Nov預期
Q3 2025
-0.99
-0.97
-0.94
-0.91
預期EPS
-0.9077355
實際EPS
-0.9941865

其他人也在關注

此清單是根據在 Stock Events 上追蹤 B9P1.STU 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Show more...
執行長
Mr. Michael Kazley
員工
13
國家
美國
ISIN
US66987P5089

上市

0 Comments

分享你的想法

FAQ

Stablecoin Development 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Stablecoin Development 的股票以代號 B9P1.STU 進行交易。
Stablecoin Development 上一季度的財報如何?
B9P1.STU 上一季度的財報為每股 -0.99 EUR,預估為 -0.91 EUR,帶來 -9.52% 的驚喜。下一季度的預估財報為每股 不適用 EUR。
Stablecoin Development 有多少名員工?
截至 April 12, 2026,公司共有 13 名員工。
Stablecoin Development 位於哪個產業?
Stablecoin Development從事於Health & Wellness產業。
Stablecoin Development 何時完成拆股?
Stablecoin Development 最近沒有進行任何拆股。
Stablecoin Development 的總部在哪裡?
Stablecoin Development 的總部位於 美國 的 Emeryville。